IRS1 and metabolic dysfunction-associated steatotic liver disease: It should be noted that increased pathogenic factors in portal circulation may result from gut dysbiosis in MASLD patients [20]. Nevertheless, these proinflammatory cytokines, NF-kB, and oxidative stress have been shown as factors indirectly inhibiting downstream signaling of IRS1 and IRS2 [20].